Companies / Maryland / NextCure

· rebuilt nightly from public records

Signal Sheet

Selling to NextCure? Who to reach and why now

Baltimore, Maryland is home to NextCure, a publicly listed pharmaceutical preparations company. It raised $21.5M in Nov 2025 and its filings name 12 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Maryland

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerMichael RichmanSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerSteven P. CobournSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerUdayan GuhaSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerTimothy MayerSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerSourav KunduSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerKevin ShawSEC filing, Nov 2025Named officer in the filing; part of the buying group
Chief Technology OfficerDavid KabakoffSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerElaine V. JonesSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerJohn G. HoustonSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerStephen WebsterSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerEllen G. FeigalSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerAnne BorgmanSEC filing, Nov 2025Technology and tooling decisions
For sellersWhy NextCure is worth a call this quarterBuy Window: open · new leadership Oct 2026
Oct 26Oct 2026

New leadership

Officer or director change

New leadership
Sep 2026Sep 2026

Corporate event

Signed a material agreement

Corporate event
$21.5M

Raised

Equity raise reported to the SEC, Nov 2025. Money arrives before the spending plan does.

Capital
Track NextCure with a free trial →Get the next signal the day it is filed or posted.
Email me the next NextCure signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 26, 2026Officer or director changeNew leadershipSEC filing
Sep 3, 2026Signed a material agreementCorporate eventSEC filing
Nov 12, 2025Raised $21.5M in equity from 12 investorsCapitalSEC filing

Reach NextCure with emails that land

Lakewave finds the right people at NextCure, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on NextCure with a free trial →

About NextCure

HeadquartersBaltimore, Maryland, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$21.5M (Nov 2025)
Lakewave Rising15 · 2 kinds of evidence · rank in Maryland after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Theriva Biologics · 28Emergent Biosolutions · 10Shuttle Pharmaceuticals · 5United TherapeuticsSee all 4 with a free trial →

Questions people ask

Did NextCure raise funding in 2025?

Yes. NextCure reported a $21.5M equity raise to the SEC on Nov 12, 2025 with 12 investors.

Who runs NextCure?

The company's SEC filing, Nov 2025 names Michael Richman (Executive Officer) among its officers.

Where is NextCure headquartered?

Baltimore, Maryland, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.